Edition:
United Kingdom

Organovo Holdings Inc (ONVO.OQ)

ONVO.OQ on NASDAQ Stock Exchange Global Market

1.39USD
8 Dec 2017
Change (% chg)

$-0.04 (-2.80%)
Prev Close
$1.43
Open
$1.42
Day's High
$1.44
Day's Low
$1.38
Volume
203,993
Avg. Vol
225,431
52-wk High
$4.07
52-wk Low
$1.33

Chart for

About

Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products,... (more)

Overall

Beta: 3.21
Market Cap(Mil.): $215.48
Shares Outstanding(Mil.): 105.63
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.65 16.44
EPS (TTM): -- -- --
ROI: -- 2.35 10.62
ROE: -- 2.95 14.20

BRIEF-Organovo posts Q3 loss per share $0.09

* Organovo announces fiscal second-quarter 2018 results; company shifts commercial focus to higher-value disease modeling opportunities and updates full-year fiscal 2018 outlook

09 Nov 2017

BRIEF-Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease

* Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease

06 Nov 2017

BRIEF-Organovo reports Q1 loss per share $0.10

* Organovo announces fiscal first-quarter 2018 results; company affirms full-year fiscal 2018 outlook

09 Aug 2017

Earnings vs. Estimates